drugset / Trial / NCT00568789

Safety of Ramelteon in Elderly Subjects

NCT00568789

Phase 4 Completed 33 enrolled Takeda
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to investigate the effects of ramelteon in elderly subjects on balance, mobility and memory impairment after awakening in the middle of the night following bedtime dosing.

Timeline

Start
2006-06
Primary completion
2006-09
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramelteon Unknown 8 mg Oral
Subject Zolpidem Small molecule 10 mg Oral

Indications